Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Not Available].

S Cosentino1, B Cacopardo, B M Celesia

  • 1Istituto di Malattie Infettive dell'Università di Catania, Italy.

Le Infezioni in Medicina
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is it time to introduce health coaching in inflammatory bowel disease management?

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2025
Same author

Forensic investigation on a combined death by food aspiration and acute escitalopram intoxication occurred to a psychiatric subject in a nursing home.

International journal of legal medicine·2024
Same author

Lethal vortioxetine poisoning? A forensic investigation.

Legal medicine (Tokyo, Japan)·2023
Same author

Evaluate the safety and efficacy of dura sealant patch in reducing cerebrospinal fluid leakage following elective cranial surgery (ENCASE II): study protocol for a randomized, two-arm, multicenter trial.

Trials·2022
Same author

Containment effort reduction and regrowth patterns of the Covid-19 spreading.

Infectious Disease Modelling·2021
Same author

MRI T2-Hyperintense Signal Structures in the Cervical Spinal Cord: Anterior Median Fissure versus Central Canal in Chiari and Control-An Exploratory Pilot Analysis.

AJNR. American journal of neuroradiology·2021
Same journal

Rezafungin and catheter-related candidemia: a new player in a high-stakes game.

Le infezioni in medicina·2026
Same journal

Effectiveness and Safety Profile of BIC/TAF/FTC in People living with HIV Switched from Other Antiretroviral Regimens: A Real-Life Retrospective Cohort Analysis.

Le infezioni in medicina·2026
Same journal

Insights into parvovirus B19 clinical and virological dynamics among blood donors.

Le infezioni in medicina·2026
Same journal

When Faster Diagnosis Is Not Enough: Bringing Diagnostic Stewardship into Antimicrobial Stewardship.

Le infezioni in medicina·2026
Same journal

Fragility of Immunisation and Water Systems in Gaza: Infectious Disease Risks in a Conflict-Affected Setting.

Le infezioni in medicina·2026
Same journal

HIV-2 infection in Europe - persistence by migrant flows from West Africa but low spillover into the native population.

Le infezioni in medicina·2026
See all related articles

Thalidomide effectively treated severe ulcerative disease in an AIDS patient, resolving oral pain and dysphagia. This treatment offers a promising option for similar gastrointestinal conditions in immunocompromised individuals.

Area of Science:

  • Immunology
  • Gastroenterology
  • Infectious Diseases

Context:

  • A patient with Acquired Immunodeficiency Syndrome (AIDS) presented with severe oro-pharyngeal and oesophageal ulcerative disease.
  • Symptoms included significant oral pain, dysphagia, fever, and fatigue.
  • Previous treatments with antibiotics, antivirals, corticosteroids, and colchicine were ineffective.

Purpose:

  • To evaluate the efficacy of thalidomide in treating severe ulcerative gastrointestinal disease in an AIDS patient.

Summary:

  • Thalidomide was administered at 200 mg/day for 21 days, followed by 100 mg/day for 25 days.
  • A significant reduction in symptoms was observed within 15 days of treatment initiation.
  • Complete ulcer healing was noted one month after commencing thalidomide therapy, with no major adverse effects.

Related Experiment Videos

Impact:

  • Thalidomide demonstrates potential as a successful therapeutic agent for severe ulcerative gastrointestinal conditions in AIDS patients at low risk for side effects.
  • This case highlights a viable treatment option for refractory gastrointestinal ulcerations in immunocompromised populations.